Effective Assessment of Diabetes Control Using Personal Glucometers (CONTOURLINK, Bayer, Germany; CALLA, Wellion, Austria; LINUS, Agamatrix, USA)

<table>Improvement of the AGP (Figure <a href="../fig10/">10</a>) is likely due to increasing metformin dose to 3000 mg/d. Form filled by the patient.</table>

Disease Markers

fig11

Figure 11

Figure 11: Effective Assessment of Diabetes Control Using Personal Glucometers (CONTOURLINK, Bayer, Germany; CALLA, Wellion, Austria; LINUS, Agamatrix, USA) 

Figure 11 | Effective Assessment of Diabetes Control Using Personal Glucometers (CONTOURLINK, Bayer, Germany; CALLA, Wellion, Austria; LINUS, Agamatrix, USA) 